We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fresh From $750M Settlement, Medinol To Pursue Further Royalties From Boston Scientific

Law360 (September 27, 2005, 12:00 AM EDT) -- Israeli medical device maker Medinol, fresh from winning a $750 million settlement from Boston Scientific Corp. over sales of coronary stents, plans to pursue future royalties on a next-generation stent, according...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.